| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.083 | 0.02 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | 0.073 | 0.02 |
| mRNA | PD173074 | GDSC1000 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | -0.081 | 0.02 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.02 |
| mRNA | BAY 61-3606 | GDSC1000 | pan-cancer | AAC | 0.077 | 0.02 |
| mRNA | Merck60 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.02 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | 0.066 | 0.02 |
| mRNA | Vorinostat | GDSC1000 | pan-cancer | AAC | 0.069 | 0.03 |
| mRNA | KU-55933 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.03 |